Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition-Reference-Cited by-同舟云学术

Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition

Published:2012-11-28 Issue:6 Volume:61 Page:1125-1133
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Koay Mei Hui E,Crook Maxine,Stewart Colin J R

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2012.04326.x/fullpdf

Reference40 articles.

1. Micro-invasive squamous cell carcinoma of the cervix - a clinicopathologic study of 200 cases with long term follow-up;Ostor;Int. J. Gynecol. Cancer,1994

2. Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA);Burghardt;Cancer,1991

3. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium;Pecorelli;Int. J. Gynecol. Obstet.,2009

4. Squamous carcinoma of the uterine cervix with CIN 3-like pattern: an under-diagnosed lesion;Al Nafussi;Int. J. Gynecol. Cancer,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High M2-TAM Infiltration and STAT3/NF-κB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer;Cancers;2024-07-09

2. Cervical Squamous Neoplasia;Gynecologic and Obstetric Pathology;2024

3. Study of expression of epithelial cadherin in benign and malignant epithelial lesions of uterine cervix;Journal of Datta Meghe Institute of Medical Sciences University;2022

4. Epithelial–mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement;Journal of Cancer Research and Clinical Oncology;2021-09-08

5. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing;BMC Cancer;2020-07-25